Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Prospective Randomized Trial Comparing Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting in the Treatment of Gastrointestinal Cancer

NCT00971399 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT00971399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00971399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Prospective Randomized Trial Comparing Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting in the Treatment of Gastrointestinal Cancer
Lead sponsor
Seoul National University Hospital
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2009
Completion date
Not reported
Enrollment
172 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radiotherapy induced nausea and vomiting